Hummingbird Diagnostics GmbH
Hummingbird Diagnostics is a privately held company based in Heidelberg, Germany, that develops next-generation molecular blood tests for precision medicine. Their platform integrates the analysis of tumor and immune system biomarkers, focusing on small RNA analysis from whole blood. This dual approach aims to revolutionize disease diagnosis, treatment, and management, particularly in oncology. Key products include miLung for early lung cancer detection with improved sensitivity, miRisk for guiding immunotherapy use in lung cancer by predicting response, and miTrack for non-invasive monitoring of cancer treatment response and recurrence. The company leverages AI and machine learning in its platform, 'mirCator', and has a strong focus on improving outcomes for patients with cancer and other diseases.
Hummingbird Diagnostics GmbH
Hummingbird Diagnostics is a privately held company based in Heidelberg, Germany, that develops next-generation molecular blood tests for precision medicine. Their platform integrates the analysis of tumor and immune system biomarkers, focusing on small RNA analysis from whole blood. This dual approach aims to revolutionize disease diagnosis, treatment, and management, particularly in oncology. Key products include miLung for early lung cancer detection with improved sensitivity, miRisk for guiding immunotherapy use in lung cancer by predicting response, and miTrack for non-invasive monitoring of cancer treatment response and recurrence. The company leverages AI and machine learning in its platform, 'mirCator', and has a strong focus on improving outcomes for patients with cancer and other diseases.